New U.S. cancer drug prices increase 53 pct in 5 yrs: report
Nov 04, 2022
London [UK], November 4: The annual price of a newly-launched cancer drug in the United States averaged 283,000 U.S. dollars last year, a 53 percent increase from 2017, Reuters has reported.